BPIQ Blog

Mar 18, 20192 min read

FDA Accepts AIMT's Peanut Allergy Treatment BLA For Review

AIMT is seeking approval for AR101 as a treatment to reduce the risk of anaphylaxis following accidental exposure to peanuts in children...

Jump start your biotech due diligence

Our platform helps you uncover your next biotech investment opportunity

bottom of page